NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ImmunotherapyYoshihiro Otani, Balveen Kaur, Ji Young Yoo et al.|Clinical Cancer Research|2022Cited by 58
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Ji Young Yoo, Minxin Huang et al.|Neuro-Oncology|2024Cited by 22
Supplementary Data from NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor ImmunotherapyYoshihiro Otani, Balveen Kaur, Ji Young Yoo et al.|Unknown|2023Cited by 1
EXTH-76. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA NEUROSPHERES TO TEMOZOLOMIDESarah Rivas, Yeshavanath Banasavadi-Siddegowda, Kimberly Rivera-Caraballo et al.|Neuro-Oncology|2022Cited by 1
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Sridharan Jayamohan et al.|Research Square|2025Cited by 1